Virtu Financial LLC Adaptimmune Therapeutics PLC Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

A detailed history of Virtu Financial LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Virtu Financial LLC holds 101,008 shares of ADAP stock, worth $66,665. This represents 0.01% of its overall portfolio holdings.

Number of Shares
101,008
Previous 79,239 27.47%
Holding current value
$66,665
Previous $77,000 24.68%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024
BUY
$0.92 - $1.39 $20,027 - $30,258
21,769 Added 27.47%
101,008 $96,000
Q2 2024

Aug 09, 2024
BUY
$0.83 - $1.47 $65,768 - $116,481
79,239 New
79,239 $77,000
Q4 2023

Feb 26, 2024
BUY
$0.43 - $0.79 $12,214 - $22,440
28,406 New
28,406 $23,000
Q1 2023

May 01, 2023
BUY
$1.06 - $2.16 $61,618 - $125,562
58,131 Added 193.11%
88,234 $96,000
Q4 2022

Feb 15, 2023
SELL
$1.05 - $2.53 $10,920 - $26,311
-10,400 Reduced 25.68%
30,103 $44,000
Q3 2022

Nov 07, 2022
BUY
$1.06 - $2.41 $24,565 - $55,851
23,175 Added 133.74%
40,503 $44,000
Q2 2022

Aug 09, 2022
SELL
$1.33 - $2.28 $9,498 - $16,283
-7,142 Reduced 29.19%
17,328 $29,000
Q1 2022

May 17, 2022
BUY
$1.73 - $4.06 $42,333 - $99,348
24,470 New
24,470 $50,000
Q4 2021

Feb 17, 2022
SELL
$3.5 - $5.68 $166,397 - $270,038
-47,542 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$3.44 - $6.37 $163,544 - $302,842
47,542 New
47,542 $246,000
Q3 2020

Dec 11, 2020
SELL
$7.66 - $10.78 $152,012 - $213,929
-19,845 Closed
0 $0
Q2 2020

Aug 07, 2020
BUY
$2.58 - $12.1 $51,200 - $240,124
19,845 New
19,845 $199,000
Q1 2018

May 14, 2018
SELL
$7.1 - $11.56 $429,358 - $699,067
-60,473 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$6.68 - $8.74 $216,578 - $283,368
32,422 Added 115.58%
60,473 $404,000
Q3 2017

Nov 15, 2017
BUY
$4.93 - $8.93 $138,291 - $250,495
28,051
28,051 $0

Others Institutions Holding ADAP

# of Institutions
82
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $108M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email